粒体自噬
脂肪性肝炎
细胞生物学
线粒体
调节器
激酶
生物
PI3K/AKT/mTOR通路
磷酸化
品脱1
坦克结合激酶1
雷帕霉素的作用靶点
自噬
溶酶体
mTORC1型
化学
癌症研究
活性氧
脂肪肝
蛋白激酶B
作者
Sung-Min An,Jun Hee Jang,Jin Hyun Sung,Ji Won Myung,Yong Geun Jeon,Won Taek Lee,Jin Won Jeon,Kyung Min Yim,Jae-Ho Lee,Bichen Zhang,Jong Bae Seo,Seung Soon Im,Jae Bum Kim,A. R. Saltiel,Jin Young Huh
标识
DOI:10.1038/s12276-026-01672-9
摘要
Abstract Mitochondrial dysfunction is a critical driver of metabolic dysfunction-associated steatotic liver disease progression to steatohepatitis (MASH), yet the mechanisms governing mitochondrial quality control in hepatocytes remain poorly defined. Here we identify TANK-binding kinase 1 (TBK1) as an essential regulator of hepatic mitophagy and lysosomal activity. Using TBK1-deficient hepatocytes and liver-specific TBK1-knockout mice, we show that TBK1 loss leads to the accumulation of depolarized, reactive oxygen species-producing mitochondria due to impaired mitophagy flux, including defective lysosomal degradation. Mechanistically, TBK1 is required for p62 phosphorylation at Ser403 and partially modulates mTOR signaling to preserve lysosomal activity. Notably, both human samples and murine steatohepatitis models exhibited a substantial decline in TBK1 kinase activity. Therapeutic restoration of TBK1 expression via AAV8 delivery in MASH mouse model enhanced mitophagy, reduced mitochondrial burden and ameliorated liver fibrosis. Collectively, these findings establish TBK1 as a critical guardian of mitochondrial and lysosomal homeostasis in MASH.
科研通智能强力驱动
Strongly Powered by AbleSci AI